Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.

Purpose: Guidelines from the National Institutes of Health support the use of balanced crystalloid solutions such as Normosol-R (Hospira, Lake Forest, IL) for patients with coronavirus disease 2019 (COVID-19). However, their clinical utility is hindered by a lack of Y-site compatibility data that is essential for use in patients with limited intravenous access. The objective of this study was to determine the physical compatibility of selected intensive care unit medications with Normosol-R.

Pool chemical blast injury.

Swimming pools are one of the most popular forms of recreation in the United States. Pool-related injuries may produce significant morbidity and mortality, and those related to pool chemicals are of particular importance. The majority of injuries associated with pool chemicals are respiratory, with the remainder composed mainly of dermal exposures.